In early detection, diagnosis, prognosis and therapy, tumor-specific molecules play a significant role across all the areas of oncology. The growing number of public databases of transcriptome (mRNA) sequences yielded from tumors and healthy tissue hold massive data for comparison and discovery of tumor-specific molecules. Identifying molecules specifically related to tumors holds the key in early detection, diagnosis and treatment in any field of oncology. Specific biomolecules indicate and confirm the presence of relevant cancer type.
However, the detection of these molecules is a very challenging task and cannot be performed only by biochemical assays. The intermolecular and intramolecular differences of such molecules are very critical to understand the specificity of cancer. The new genomic approach in the detection of such molecules targeted alterations in the DNA. Now, the…
